Developer docs
API playgroundTry for free, no card

Search company profiles

Brilliant Bio Pharma

Full company profile

uuid000jemc

Namestring
Brilliant Bio Pharma
Legal namestring
Brilliant Bio Pharma Private Limited
Company typeenum
Private
Founded yearint
1998
Descriptiontext

Brilliant Bio Pharma Private Limited, headquartered in Hyderabad, India, manufactures veterinary vaccines and animal health products for livestock (cattle, sheep, goats) and companion animals (canines). Its portfolio spans inactivated and live attenuated vaccines targeting Foot-and-Mouth Disease (FMD), rabies, bluetongue, Peste des Petits Ruminants (PPR), sheep pox, haemorrhagic septicaemia, blackquarter, and enterotoxaemia, complemented by animal health products including dry powders, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-parasiticides.

The company operates one of the world's largest Biosafety Level 3 (BSL-3) containment manufacturing facilities, with fully automated 500L to 10KL bioreactors used for propagation of FMD, Bluetongue, and Rabies viruses—reportedly the first deployment of 10KL fermenters for FMD vaccine production in India. Manufacturing processes are ISO 9001:2015 certified and compliant with cGMP, GLP, and OIE (World Organisation for Animal Health) guidelines, and the R&D function is housed in a DSIR-certified laboratory capable of mammalian cell culture propagation in both suspension (100L to 10KL) and adherent systems. Cumulative output has scaled from 230,000 doses in 2005 to over 1.5 billion doses globally, with anti-rabies vaccine capacity at 20 million doses per annum and an automated vial-filling line rated at 60,000 PP vials (equivalent to 3 million doses) per day in open RABS aseptic conditions.

Brilliant Bio Pharma monetises through one-time product sales of vaccines and biologics, distributed across India through a channel comprising a 150-person field force, 12 CFA offices, super distributors, and over 1,000 active distributors serving practising veterinarians, retail and institutional segments, dairy co-operatives, corporate dairies, and NGOs. The company is a main stakeholder in the Government of India's FMD Immunisation Programme and holds Star Export House status for international vaccine exports into emerging markets. No third-party manufacturing, licensing, or subscription revenue is disclosed; pricing is governed by government tenders and distributor agreements.

Short descriptiontext

Brilliant Bio Pharma is a Hyderabad-based veterinary vaccine and animal health manufacturer producing inactivated and live attenuated vaccines for livestock and companion animals in BSL-3 facilities, sold via pan-India distributors and to the Government of India's FMD immunisation programme.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersHyderabad, India
HQ citystring
Hyderabad
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary vaccines, animal health products, livestock biologicals, parasiticides antibiotics, canine wellness products
Industry4 codes
PRIMARYHLAMAKAB
Livestock Vaccines (Cattle, Swine, Sheep & Goats)
SECONDARYHLAMAEAL
Veterinary Vaccines (Biologics)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAIAEAH
Veterinary Vaccines
SECONDARYHLAMAKAM
Vaccine R&D, Clinical/Field Trials & Regulatory Affairs
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Veterinary Vaccines and Biologicals
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Veterinary Vaccines and Biologicals
TypeOne Time License
Description

Sale of veterinary vaccines and biologicals across bovine, ovine, canine, and other animal species. Revenue generated through product sales to government vaccination programmes, dairy co-operatives, corporate dairies, veterinarians, and distributor networks across India and global markets.

brilliantbiopharma.com
2Animal Health Products (AHPs)
TypeOne Time License
Description

Broader portfolio of animal health products including dry powder, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-parasiticides sold alongside vaccines.

brilliantbiopharma.com
3Manufacturing Services
TypeProfessional Services
Description

Manufacturing capabilities for third-party or contract vaccine production implied by large-scale BSL-3 facility and 10KL bioreactor capacity, though explicit third-party manufacturing agreements are not disclosed.

brilliantbiopharma.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Brilliant Bio Pharma manufactures and sells veterinary vaccines and animal health products for bovines, ovines/caprines, and canines. The portfolio includes inactivated and live attenuated vaccines for Foot-and-Mouth Disease, Rabies, Bluetongue, Haemorrhagic Septicaemia, Blackquarter, PPR, Sheep Pox, and Enterotoxaemia, complemented by dry powder, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-parasiticides. Production occurs in one of the world's largest BSL-3 containment facilities using automated 10KL bioreactors, with annual capacity of 1.5 billion doses.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 1.5 billion doses of animal vaccines delivered globally, grown from 2.30 lakh doses in 2005
+3 more records
Product overview1 text field

Brilliant Bio Pharma is a veterinary vaccines and animal health products company offering a unified portfolio of biologicals and wellness products for livestock and companion animals. The product range includes vaccines for Bovines (FMD, Haemorrhagic Septicaemia, Blackquarter, Rabies), Ovines/Caprines (Enterotoxaemia, Bluetongue, PPR, Sheep Pox), and Canines (Rabies). The company manufactures veterinary vaccines in BSL-3 certified facilities using automated bioreactors and fermentation technology, producing both individual vaccines and combined formulations. Key products include inactivated vaccines (FMD, Bluetongue, Rabies), live attenuated vaccines (PPR, Sheep Pox), and combined vaccines (FMD+HS, HS+Blackquarter). The portfolio is complemented by biologicals, dry powder, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-paraciticides for comprehensive animal health management.

Product and service10 records
1Rabies Veterinary Vaccine (Cell Culture), Inactivated IP
CategoryVeterinary Vaccines - Companion Animals / Livestock
Description

Inactivated cell culture-based veterinary vaccine for rabies prophylaxis in animals, compliant with Indian Pharmacopoeia (IP) standards, targeted at companion animals and livestock.

2Foot-and-Mouth Disease Vaccine, Inactivated IP
CategoryVeterinary Vaccines - Bovines
Description

Inactivated vaccine for Foot-and-Mouth Disease targeting cattle and other cloven-hoofed animals, manufactured in BSL-3 facility using 10KL fermenters.

3Haemorrhagic Septicaemia Vaccine IP
CategoryVeterinary Vaccines - Bovines
Description

Vaccine for Haemorrhagic Septicaemia caused by Pasteurella multocida in cattle and buffalo.

4Blackquarter Vaccine IP
CategoryVeterinary Vaccines - Bovines
Description

Vaccine for Blackquarter (Blackleg) disease in cattle caused by Clostridium chauvoei.

5Haemorrhagic Septicaemia + Blackquarter Vaccine
CategoryVeterinary Vaccines - Bovines (Combined)
Description

Combined bivalent vaccine providing protection against both Haemorrhagic Septicaemia and Blackquarter in cattle.

6Enterotoxaemia Vaccine IP
CategoryVeterinary Vaccines - Ovines/Caprines
Description

Vaccine for Enterotoxaemia (Pulpy Kidney disease) in sheep and goats caused by Clostridium perfringens.

7Bluetongue Vaccine, Inactivated IP
CategoryVeterinary Vaccines - Ovines/Caprines
Description

Inactivated vaccine for Bluetongue disease in sheep and goats, compliant with Indian Pharmacopoeia standards.

8Peste Des Petits Ruminants Live, Freeze Dried Vaccine IP
CategoryVeterinary Vaccines - Ovines/Caprines
Description

Live attenuated freeze-dried vaccine for Peste Des Petits Ruminants (PPR) targeting sheep and goats.

9Sheep Pox Vaccine, Live Attenuated IP, Freeze Dried Vaccine IP
CategoryVeterinary Vaccines - Ovines/Caprines
Description

Live attenuated freeze-dried vaccine for Sheep Pox disease in ovine species.

10Foot-and-Mouth Disease + Haemorrhagic Septicaemia Vaccine
CategoryVeterinary Vaccines - Bovines (Combined)
Description

Combined vaccine providing simultaneous protection against Foot-and-Mouth Disease and Haemorrhagic Septicaemia in cattle.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Govt. of India (FMD Immunisation Programme)
Strategic tierCoreTypeOthersAnnounced on2025-08-14
Description

Brilliant Bio Pharma is one of the main stakeholders in Govt. of India's FMD Control/Immunisation Programme, supplying FMD vaccines for national vaccination campaigns. This government partnership represents a core strategic relationship for the company.

futuremarketinsights.com
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Elanco is a major global animal health company with a livestock vaccines portfolio and a strong presence in emerging markets, competing broadly with Brilliant Bio Pharma in the veterinary biologics and government tender space.

TypeBroad incumbent
Description

MSD Animal Health is a global leader in livestock and companion animal vaccines, including FMD and rabies, competing with Brilliant Bio Pharma for share in global veterinary vaccine markets and emerging-market government programmes.

TypeBroad incumbent
Description

Ceva Santé Animale is a global animal health company with a growing livestock and poultry vaccine business, particularly active in emerging markets where it competes with regional players like Brilliant Bio Pharma in FMD and small-ruminant vaccines.

TypeBroad incumbent
Description

Phibro Animal Health is a global animal health and nutrition company with livestock vaccines and health products, competing with Brilliant Bio Pharma in dairy and livestock segments, especially across Asia and the Middle East.

TypeDirect peer
Description

Biovet is an Indian veterinary biologics company producing FMD and livestock vaccines, operating in the same product category as Brilliant Bio Pharma and competing for government and dairy cooperative customers in India.

TypeEmerging player
Description

Vetoquinol is a European-headquartered animal health company with livestock and companion animal products, including growing presence in emerging markets where it competes for share with regional vaccine manufacturers like Brilliant Bio Pharma.

TypeDirect peer
Description

Hester Biosciences is an Indian veterinary vaccines and animal health company producing vaccines for poultry, livestock, and companion animals, directly overlapping with Brilliant Bio Pharma's livestock vaccine portfolio and India distribution model.

TypeBroad incumbent
Description

Zoetis is the world's largest animal health company with a broad portfolio of livestock and companion animal vaccines, including FMD, and competes globally with Brilliant Bio Pharma in the veterinary biologics space, especially for emerging-market and government tenders.

TypeDirect peer
Description

Indian Immunologicals Ltd is a leading Indian veterinary vaccine manufacturer with a strong FMD vaccine franchise and government programme participation, directly competing with Brilliant Bio Pharma in India's livestock biologics market across cattle, sheep, and goats.

10Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Boehringer Ingelheim Animal Health (including the former Merial) is a top-three global animal health player with FMD, rabies, and livestock vaccine franchises that compete with Brilliant Bio Pharma across emerging markets and global FMD tenders.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Brilliant Bio Pharma

Veterinary Vaccines and Biologicalsbrilliantbiopharma.com

Brilliant Bio Pharma is a Hyderabad-based veterinary vaccine and animal health manufacturer producing inactivated and live attenuated vaccines for livestock and companion animals in BSL-3 facilities, sold via pan-India distributors and to the Government of India's FMD immunisation programme.

What Brilliant Bio Pharma does

Brilliant Bio Pharma Private Limited, headquartered in Hyderabad, India, manufactures veterinary vaccines and animal health products for livestock (cattle, sheep, goats) and companion animals (canines). Its portfolio spans inactivated and live attenuated vaccines targeting Foot-and-Mouth Disease (FMD), rabies, bluetongue, Peste des Petits Ruminants (PPR), sheep pox, haemorrhagic septicaemia, blackquarter, and enterotoxaemia, complemented by animal health products including dry powders, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-parasiticides.

The company operates one of the world's largest Biosafety Level 3 (BSL-3) containment manufacturing facilities, with fully automated 500L to 10KL bioreactors used for propagation of FMD, Bluetongue, and Rabies viruses—reportedly the first deployment of 10KL fermenters for FMD vaccine production in India. Manufacturing processes are ISO 9001:2015 certified and compliant with cGMP, GLP, and OIE (World Organisation for Animal Health) guidelines, and the R&D function is housed in a DSIR-certified laboratory capable of mammalian cell culture propagation in both suspension (100L to 10KL) and adherent systems. Cumulative output has scaled from 230,000 doses in 2005 to over 1.5 billion doses globally, with anti-rabies vaccine capacity at 20 million doses per annum and an automated vial-filling line rated at 60,000 PP vials (equivalent to 3 million doses) per day in open RABS aseptic conditions.

Brilliant Bio Pharma monetises through one-time product sales of vaccines and biologics, distributed across India through a channel comprising a 150-person field force, 12 CFA offices, super distributors, and over 1,000 active distributors serving practising veterinarians, retail and institutional segments, dairy co-operatives, corporate dairies, and NGOs. The company is a main stakeholder in the Government of India's FMD Immunisation Programme and holds Star Export House status for international vaccine exports into emerging markets. No third-party manufacturing, licensing, or subscription revenue is disclosed; pricing is governed by government tenders and distributor agreements.

Brilliant Bio Pharma firmographics

Firmographics
Name
Brilliant Bio Pharma
Legal name
Brilliant Bio Pharma Private Limited
Website
https://brilliantbiopharma.com
Company type
Private
Founded year
1998
Operating status
Operating
Headcount range
101–250 employees
Short description
Brilliant Bio Pharma is a Hyderabad-based veterinary vaccine and animal health manufacturer producing inactivated and live attenuated vaccines for livestock and companion animals in BSL-3 facilities, sold via pan-India distributors and to the Government of India's FMD immunisation programme.
Ownership category
akta.pro rank

Brilliant Bio Pharma industry classification

Industry
Product category
Veterinary Vaccines and Biologicals
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAMAKAB
Livestock Vaccines (Cattle, Swine, Sheep & Goats)
SECONDARYHLAMAEAL
Veterinary Vaccines (Biologics)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAIAEAH
Veterinary Vaccines
SECONDARYHLAMAKAM
Vaccine R&D, Clinical/Field Trials & Regulatory Affairs

Keywords

  • Veterinary vaccines
  • Animal health products
  • Livestock biologicals
  • Parasiticides antibiotics
  • Canine wellness products

Where Brilliant Bio Pharma is headquartered

Location

Headquarters

HQ city
Hyderabad
HQ country
India
HQ region
Asia

Offices1 record

Markets served

Brilliant Bio Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Veterinary Vaccines and Biologicals: Sale of veterinary vaccines and biologicals across bovine, ovine, canine, and other animal species. Revenue generated through product sales to government vaccination programmes, dairy co-operatives, corporate dairies, veterinarians, and distributor networks across India and global markets.
  2. Animal Health Products (AHPs): Broader portfolio of animal health products including dry powder, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-parasiticides sold alongside vaccines.
  3. Manufacturing Services: Manufacturing capabilities for third-party or contract vaccine production implied by large-scale BSL-3 facility and 10KL bioreactor capacity, though explicit third-party manufacturing agreements are not disclosed.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Brilliant Bio Pharma product offering

Product offering

Core offering

Brilliant Bio Pharma manufactures and sells veterinary vaccines and animal health products for bovines, ovines/caprines, and canines. The portfolio includes inactivated and live attenuated vaccines for Foot-and-Mouth Disease, Rabies, Bluetongue, Haemorrhagic Septicaemia, Blackquarter, PPR, Sheep Pox, and Enterotoxaemia, complemented by dry powder, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-parasiticides. Production occurs in one of the world's largest BSL-3 containment facilities using automated 10KL bioreactors, with annual capacity of 1.5 billion doses.

Product overview

Brilliant Bio Pharma is a veterinary vaccines and animal health products company offering a unified portfolio of biologicals and wellness products for livestock and companion animals. The product range includes vaccines for Bovines (FMD, Haemorrhagic Septicaemia, Blackquarter, Rabies), Ovines/Caprines (Enterotoxaemia, Bluetongue, PPR, Sheep Pox), and Canines (Rabies). The company manufactures veterinary vaccines in BSL-3 certified facilities using automated bioreactors and fermentation technology, producing both individual vaccines and combined formulations. Key products include inactivated vaccines (FMD, Bluetongue, Rabies), live attenuated vaccines (PPR, Sheep Pox), and combined vaccines (FMD+HS, HS+Blackquarter). The portfolio is complemented by biologicals, dry powder, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-paraciticides for comprehensive animal health management.

Differentiator

Problem solved

Functional benefit

Products and services

  • Rabies Veterinary Vaccine (Cell Culture), Inactivated IP Inactivated cell culture-based veterinary vaccine for rabies prophylaxis in animals, compliant with Indian Pharmacopoeia (IP) standards, targeted at companion animals and livestock.
  • Foot-and-Mouth Disease Vaccine, Inactivated IP Inactivated vaccine for Foot-and-Mouth Disease targeting cattle and other cloven-hoofed animals, manufactured in BSL-3 facility using 10KL fermenters.
  • Haemorrhagic Septicaemia Vaccine IP Vaccine for Haemorrhagic Septicaemia caused by Pasteurella multocida in cattle and buffalo.
  • Blackquarter Vaccine IP Vaccine for Blackquarter (Blackleg) disease in cattle caused by Clostridium chauvoei.
  • Haemorrhagic Septicaemia + Blackquarter Vaccine Combined bivalent vaccine providing protection against both Haemorrhagic Septicaemia and Blackquarter in cattle.
  • Enterotoxaemia Vaccine IP Vaccine for Enterotoxaemia (Pulpy Kidney disease) in sheep and goats caused by Clostridium perfringens.
  • Bluetongue Vaccine, Inactivated IP Inactivated vaccine for Bluetongue disease in sheep and goats, compliant with Indian Pharmacopoeia standards.
  • Peste Des Petits Ruminants Live, Freeze Dried Vaccine IP Live attenuated freeze-dried vaccine for Peste Des Petits Ruminants (PPR) targeting sheep and goats.
  • Sheep Pox Vaccine, Live Attenuated IP, Freeze Dried Vaccine IP Live attenuated freeze-dried vaccine for Sheep Pox disease in ovine species.
  • Foot-and-Mouth Disease + Haemorrhagic Septicaemia Vaccine Combined vaccine providing simultaneous protection against Foot-and-Mouth Disease and Haemorrhagic Septicaemia in cattle.

Quantifiable outcome

  • 1.5 billion doses of animal vaccines delivered globally, grown from 2.30 lakh doses in 2005
  • +3 more outcomes

Companies that use Brilliant Bio Pharma

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles5 records

Brilliant Bio Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Brilliant Bio Pharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Govt. of India (FMD Immunisation Programme)coreOthers · 14 August 2025Brilliant Bio Pharma is one of the main stakeholders in Govt. of India's FMD Control/Immunisation Programme, supplying FMD vaccines for national vaccination campaigns. This government partnership represents a core strategic relationship for the company.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Brilliant Bio Pharma competitors and assessment

Company assessment

Broad incumbents

  • Elanco Animal Health: Elanco is a major global animal health company with a livestock vaccines portfolio and a strong presence in emerging markets, competing broadly with Brilliant Bio Pharma in the veterinary biologics and government tender space.
  • MSD Animal Health: MSD Animal Health is a global leader in livestock and companion animal vaccines, including FMD and rabies, competing with Brilliant Bio Pharma for share in global veterinary vaccine markets and emerging-market government programmes.
  • Ceva Santé Animale: Ceva Santé Animale is a global animal health company with a growing livestock and poultry vaccine business, particularly active in emerging markets where it competes with regional players like Brilliant Bio Pharma in FMD and small-ruminant vaccines.
  • Phibro Animal Health: Phibro Animal Health is a global animal health and nutrition company with livestock vaccines and health products, competing with Brilliant Bio Pharma in dairy and livestock segments, especially across Asia and the Middle East.
  • Zoetis: Zoetis is the world's largest animal health company with a broad portfolio of livestock and companion animal vaccines, including FMD, and competes globally with Brilliant Bio Pharma in the veterinary biologics space, especially for emerging-market and government tenders.
  • Boehringer Ingelheim Animal Health: Boehringer Ingelheim Animal Health (including the former Merial) is a top-three global animal health player with FMD, rabies, and livestock vaccine franchises that compete with Brilliant Bio Pharma across emerging markets and global FMD tenders.

Direct peers

  • Biovet (Biovet Private Limited): Biovet is an Indian veterinary biologics company producing FMD and livestock vaccines, operating in the same product category as Brilliant Bio Pharma and competing for government and dairy cooperative customers in India.
  • Hester Biosciences: Hester Biosciences is an Indian veterinary vaccines and animal health company producing vaccines for poultry, livestock, and companion animals, directly overlapping with Brilliant Bio Pharma's livestock vaccine portfolio and India distribution model.
  • Indian Immunologicals Ltd: Indian Immunologicals Ltd is a leading Indian veterinary vaccine manufacturer with a strong FMD vaccine franchise and government programme participation, directly competing with Brilliant Bio Pharma in India's livestock biologics market across cattle, sheep, and goats.

Emerging players

  • Vetoquinol: Vetoquinol is a European-headquartered animal health company with livestock and companion animal products, including growing presence in emerging markets where it competes for share with regional vaccine manufacturers like Brilliant Bio Pharma.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Brilliant Bio Pharma social profiles

Digital presence

Brilliant Bio Pharma compliance and trust

Trust signal

Compliance4 records

Brilliant Bio Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Brilliant Bio Pharma leadership team

Management profile

Number of profiles

Profiles1 record

Brilliant Bio Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Brilliant Bio Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brilliant Bio Pharma

What does Brilliant Bio Pharma do?

Brilliant Bio Pharma manufactures and sells veterinary vaccines and animal health products for bovines, ovines/caprines, and canines. The portfolio includes inactivated and live attenuated vaccines for Foot-and-Mouth Disease, Rabies, Bluetongue, Haemorrhagic Septicaemia, Blackquarter, PPR, Sheep Pox, and Enterotoxaemia, complemented by dry powder, liquid injections, tablet/bolus preparations, feed supplements, additives, and ecto-parasiticides. Production occurs in one of the world's largest BSL-3 containment facilities using automated 10KL bioreactors, with annual capacity of 1.5 billion doses.

Is Brilliant Bio Pharma a public or private company?

Brilliant Bio Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Brilliant Bio Pharma founded?

Brilliant Bio Pharma was founded in 1998. It employs 101 to 250 people.

Where is Brilliant Bio Pharma based?

Brilliant Bio Pharma is headquartered in Hyderabad, India, in the Asia region.

How does Brilliant Bio Pharma make money?

Three revenue lines are on record. Veterinary Vaccines and Biologicals are the primary driver. The others are animal Health Products (AHPs) and manufacturing Services.

Who are Brilliant Bio Pharma's main competitors?

Broad incumbents on record are Elanco Animal Health, MSD Animal Health, Ceva Santé Animale, Phibro Animal Health, Zoetis and Boehringer Ingelheim Animal Health. Direct peers are Biovet (Biovet Private Limited), Hester Biosciences and Indian Immunologicals Ltd. Vetoquinol is listed as an emerging player.

Does Brilliant Bio Pharma have an API?

No public API is recorded for Brilliant Bio Pharma.

What industry is Brilliant Bio Pharma in?

Brilliant Bio Pharma's product category is Veterinary Vaccines and Biologicals. Its primary akta.pro industry code is HLAMAKAB, Livestock Vaccines (Cattle, Swine, Sheep & Goats), with a secondary code of HLAMAEAL, Veterinary Vaccines (Biologics). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals